Guardant Health
GH
#1635
Rank
HK$103.34 B
Marketcap
HK$795.76
Share price
3.55%
Change (1 day)
114.71%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

EPS for Guardant Health (GH)

EPS in 2025 (TTM): -HK$25.02

According to Guardant Health 's latest financial reports the company's current EPS (TTM) is -HK$25.08. In 2024 the company made an earnings per share (EPS) of -HK$27.81 an increase over its 2023 EPS that were of -HK$33.44.

EPS history for Guardant Health from 2018 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-HK$25.02-10.06%
2024-HK$27.81-16.82%
2023-HK$33.44-33.13%
2022-HK$50.0060%
2021-HK$31.2555.04%
2020-HK$20.16207.14%
2019-HK$6.56-19.81%
2018-HK$8.18

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Neogen
NEOG
-HK$21.65-13.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Natera
NTRA
-HK$16.72-33.33%๐Ÿ‡บ๐Ÿ‡ธ USA